Nccih Logo

The COVID-19 outbreak is an emerging, rapidly evolving situation.

View public health information from CDC
View research information from NIH

FDA Public Hearing on Homeopathic Product Regulation

Date: April 20, 2015

Location: Silver Spring, Maryland

Event Description

The Food and Drug Administration (FDA) is announcing a public hearing to obtain information and comments from stakeholders about the current use of human drug and biological products labeled as homeopathic, as well as the Agency’s regulatory framework for such products. These products include prescription drugs and biological products labeled as homeopathic and over-the-counter (OTC) drugs labeled as homeopathic. FDA is seeking participants for the public hearing and written comments from all interested parties, including, but not limited to, consumers, patients, caregivers, health care professionals, patient groups, and industry. FDA is seeking input on a number of specific questions, but is interested in any other pertinent information participants would like to share.

For more information: